je.st
news
Innovative Assays For Alzheimer's Disease
2013-03-07 01:31:31| drugdiscoveryonline Home Page
MPI Research, the largest single-site preclinical contract research organization worldwide, is pleased to announce that it recently completed specialized training from Meso Scale Discovery (MSD) to run Aβ42 and Total Tau immunoassays on the MSD Imager platform.
Tags: disease
innovative
assays
alzheimers
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||